Boehringer Ingelheim (Thai) Ltd.
- Rodrigo Lau – General Manager
- Yaowares Sumettavanich – Head of Market Access and Healthcare Affairs
2922/207-208, Charn Issara Tower II, 12th Floor, New Petchburi, Bangkapi, Huaykwang, Bangkok 10310
+66 2308 8515
Boehringer Ingelheim offers the range of innovative, biopharmaceutical drugs developed and manufactured by the headquarters for systematic attention to practical medical requirements - SPIRIVA® Medicines against respiratory diseases, as well as metabolic diseases and Cardiovascular and e.g. JARDIANCE® and PRADAXA®, for example.
Our products cover the spectrum from preventive vaccines and parasiticides for every type of animal we support, to therapeutic medicines that treat key diseases in certain species. We focus on developing the best format delivery mechanism for each product that maximizes effectiveness and safety, but also ease of administration e.g. NEXGARD®, FRONTLINE® and INGELVAC CIRCOFLEX®
Contact information for member only.
Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.